New advances in the treatments of drug-resistant tuberculosis-Reference-Cited by-同舟云学术

New advances in the treatments of drug-resistant tuberculosis

Published:2023-07-25 Issue:8 Volume:21 Page:863-870
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Mahmoud Mohanad¹,Tan Yurong¹^ORCID

Affiliation:

1. Department of Medical Microbiology; China-Africa Research Center of Infectious Diseases, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2023.2240022

Reference69 articles.

1. A study of multidrug resistant tuberculosis among symptomatic household contacts of MDR-TB patients

2. A CRISPR-guided mutagenic DNA polymerase strategy for the detection of antibiotic-resistant mutations in M. tuberculosis

3. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials

4. High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design

5. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges;Expert Review of Anti-infective Therapy;2024-09-04

2. Breaking barriers: The potential of nanosystems in antituberculosis therapy;Bioactive Materials;2024-09

3. From crisis to cure: harnessing the potential of mycobacteriophages in the battle against tuberculosis;Journal of Applied Microbiology;2024-08

4. Application of CRISPR–cas-based technology for the identification of tuberculosis, drug discovery and vaccine development;Molecular Biology Reports;2024-03-29

5. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs;International Journal of Molecular Sciences;2023-11-25